Teduglutide TFA, a dipeptidyl peptidase IV-resistant glucagon-like peptide-2 (GLP-2) analogue, exhibits trophic effects on the gut mucosa and is used in research related to short bowel syndrome (SBS) and Crohns disease (CD) [1] [2].
Target:
FXR|||NR4A
* VAT and and shipping costs not included. Errors and price changes excepted